AIMS: Infiltrating epitheliosis is a rare complex sclerosing lesion (CSL) of the breast, characterized by infiltrating ducts immersed in a scleroelastotic stroma and filled with cells having architectural and cytological patterns reminiscent of those of usual ductal hyperplasia. In this study we sought to define the molecular characteristics of infiltrating epitheliosis. METHODS AND RESULTS: Eight infiltrating epitheliosis, adjacent breast lesions (one usual ductal hyperplasia, one papilloma, one micropapillary ductal carcinoma in situ and one low-grade adenosquamous carcinoma), and corresponding normal breast tissue from each case were microdissected and subjected to massively parallel sequencing analysis targeting all coding regions of 254 genes mutated recurrently in breast cancer and/or related to DNA repair. Mutations in components of the PI3K pathway were found in all infiltrating epitheliosis samples, seven of which harboured PIK3CA hotspot mutations, while the remaining case displayed a PIK3R1 somatic mutation. CONCLUSIONS: Somatic mutations affecting PI3K pathway genes were found to be highly prevalent in infiltrating epitheliosis, suggesting that these lesions may be neoplastic rather than hyperplastic. The landscape of somatic genetic alterations found in infiltrating epitheliosis is similar to that of radial scars/CSLs, suggesting that infiltrating epitheliosis may represent one end of this spectrum of lesions.
AIMS: Infiltrating epitheliosis is a rare complex sclerosing lesion (CSL) of the breast, characterized by infiltrating ducts immersed in a scleroelastotic stroma and filled with cells having architectural and cytological patterns reminiscent of those of usual ductal hyperplasia. In this study we sought to define the molecular characteristics of infiltrating epitheliosis. METHODS AND RESULTS: Eight infiltrating epitheliosis, adjacent breast lesions (one usual ductal hyperplasia, one papilloma, one micropapillary ductal carcinoma in situ and one low-grade adenosquamous carcinoma), and corresponding normal breast tissue from each case were microdissected and subjected to massively parallel sequencing analysis targeting all coding regions of 254 genes mutated recurrently in breast cancer and/or related to DNA repair. Mutations in components of the PI3K pathway were found in all infiltrating epitheliosis samples, seven of which harboured PIK3CA hotspot mutations, while the remaining case displayed a PIK3R1 somatic mutation. CONCLUSIONS: Somatic mutations affecting PI3K pathway genes were found to be highly prevalent in infiltrating epitheliosis, suggesting that these lesions may be neoplastic rather than hyperplastic. The landscape of somatic genetic alterations found in infiltrating epitheliosis is similar to that of radial scars/CSLs, suggesting that infiltrating epitheliosis may represent one end of this spectrum of lesions.
Authors: Melinda E Sanders; David L Page; Jean F Simpson; Peggy A Schuyler; W Dale Plummer; William D Dupont Journal: Cancer Date: 2006-04-01 Impact factor: 6.860
Authors: Megan L Troxell; Alayne L Brunner; Tanaya Neff; Andrea Warrick; Carol Beadling; Kelli Montgomery; Shirley Zhu; Christopher L Corless; Robert B West Journal: Mod Pathol Date: 2012-03-30 Impact factor: 7.842
Authors: Charlotte K Y Ng; Anne M Schultheis; Francois-Clement Bidard; Britta Weigelt; Jorge S Reis-Filho Journal: J Natl Cancer Inst Date: 2015-02-23 Impact factor: 13.506
Authors: Sarah A Aroner; Laura C Collins; James L Connolly; Graham A Colditz; Stuart J Schnitt; Bernard A Rosner; Susan E Hankinson; Rulla M Tamimi Journal: Breast Cancer Res Treat Date: 2013-04-23 Impact factor: 4.872
Authors: Ilan Weinreb; Salvatore Piscuoglio; Luciano G Martelotto; Daryl Waggott; Charlotte K Y Ng; Bayardo Perez-Ordonez; Nicholas J Harding; Javier Alfaro; Kenneth C Chu; Agnes Viale; Nicola Fusco; Arnaud da Cruz Paula; Caterina Marchio; Rita A Sakr; Raymond Lim; Lester D R Thompson; Simion I Chiosea; Raja R Seethala; Alena Skalova; Edward B Stelow; Isabel Fonseca; Adel Assaad; Christine How; Jianxin Wang; Richard de Borja; Michelle Chan-Seng-Yue; Christopher J Howlett; Anthony C Nichols; Y Hannah Wen; Nora Katabi; Nicholas Buchner; Laura Mullen; Thomas Kislinger; Bradly G Wouters; Fei-Fei Liu; Larry Norton; John D McPherson; Brian P Rubin; Blaise A Clarke; Britta Weigelt; Paul C Boutros; Jorge S Reis-Filho Journal: Nat Genet Date: 2014-09-21 Impact factor: 38.330
Authors: Jennifer Dunlap; Claudia Le; Arielle Shukla; Janice Patterson; Ajia Presnell; Michael C Heinrich; Christopher L Corless; Megan L Troxell Journal: Breast Cancer Res Treat Date: 2009-05-06 Impact factor: 4.872
Authors: Lucia Hernandez; Paul M Wilkerson; Maryou B Lambros; Adriana Campion-Flora; Daniel Nava Rodrigues; Arnaud Gauthier; Cecilia Cabral; Vidya Pawar; Alan Mackay; Roger A'Hern; Caterina Marchiò; Jose Palacios; Rachael Natrajan; Britta Weigelt; Jorge S Reis-Filho Journal: J Pathol Date: 2012-03-21 Impact factor: 7.996
Authors: Felipe C Geyer; Fresia Pareja; Britta Weigelt; Emad Rakha; Ian O Ellis; Stuart J Schnitt; Jorge S Reis-Filho Journal: Am J Pathol Date: 2017-07-20 Impact factor: 4.307
Authors: Mothaffar F Rimawi; Carmine De Angelis; Alejandro Contreras; Fresia Pareja; Felipe C Geyer; Kathleen A Burke; Sabrina Herrera; Tao Wang; Ingrid A Mayer; Andres Forero; Rita Nanda; Matthew P Goetz; Jenny C Chang; Ian E Krop; Antonio C Wolff; Anne C Pavlick; Suzanne A W Fuqua; Carolina Gutierrez; Susan G Hilsenbeck; Marilyn M Li; Britta Weigelt; Jorge S Reis-Filho; C Kent Osborne; Rachel Schiff Journal: Breast Cancer Res Treat Date: 2017-11-07 Impact factor: 4.872
Authors: John R Lozada; Thais Basili; Fresia Pareja; Barbara Alemar; Arnaud Da Cruz Paula; Rodrigo Gularte-Merida; Dilip D Giri; Patricia Querzoli; Gabor Cserni; Emad A Rakha; Maria P Foschini; Jorge S Reis-Filho; Edi Brogi; Britta Weigelt; Felipe C Geyer Journal: Histopathology Date: 2018-06-01 Impact factor: 7.778